RXMD - Progressive Care reports strong prescriptions covid-19 rapid testing sales in November

Progressive Care (RXMD) reports November consolidated gross sales of $3.4M, up 6.3% Y/Y.Prescriptions filled during November came in at approximately 42,600, flat Y/Y. 340B fees grew 94% Y/Y in November to ~$212,000. The Company booked ~$160,000 in revenues related to rapid results COVID-19 virus testing in November, up 72% M/M. The Company has also recently completed a move into its new 11,000 sq ft pharmacy space in Hallandale Beach, Florida and plans to complete the move to its new 3,700 sq ft Orlando location before the end of January, which should drive important performance gains, advances in productivity, volume, and market reach due to the space and efficiency. “Our expanded Orlando location represents a major upgrade,” said Alan Jay Weisberg, CEO and Chairman. “In addition to driving gains in our access to the dynamic Orlando market, the move will allow us to build out our growing 340B business and dramatically expand

For further details see:

Progressive Care reports strong prescriptions, covid-19 rapid testing sales in November